CAS: 1802706-04-2
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide
CAS:1802706-04-2
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrr olo[3,4-b]pyridine-3-carboxamide is a drug candidate for the treatment of lymphocytic leukemia and other cancers. …
Formula:
C27H35F3N4O3S
Purity:
Min. 95%
Molecular weight:
552.65 g/mol
Ref: 3D-CXC70604
Undefined size | To inquire |
Estimated delivery in United States, on Monday 16 Dec 2024
(7S)-N-[[5-(Ethylsulfonyl)-2-pyridinyl]methyl]-6,7-dihydro-7-(1-methylethyl)-6-[[trans-4-(trifluoromethyl)cyclohexyl]methyl]-5H-Pyrrolo[3,4-b]pyridine-3-carboxamide
Controlled ProductCAS:1802706-04-2
Formula:
C27H35F3N4O3S
Color and Shape:
Neat
Molecular weight:
552.652
Ref: TR-E890955
75mg | 22,540.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
Vimirogant
CAS:1802706-04-2
Vimirogant is a RORγ inhibitor (Ki: <100 nM).
Formula:
C27H35F3N4O3S
Purity:
98%
Color and Shape:
Solid
Molecular weight:
552.65
Ref: TM-T16787
25mg | 2,106.00 € | ||
50mg | 2,785.00 € | ||
100mg | 3,739.00 € |
Estimated delivery in United States, on Thursday 6 Mar 2025